-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Elevance Health, Raises Price Target to $450

Benzinga·07/07/2026 11:55:10
Listen to the news
Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $400 to $450.